Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial

Mahomed, S., Garrett, N., Potloane, D., Sikazwe, I. T., Capparelli, E., Harkoo, I., Gengiah, T. N., Zuma, N. Y., Osman, F., Mansoor, L., Archary, D., Myeni, N., Radebe, P., Samsunder, N., Rose, N. D., Carlton, K., Gama, L., Koup, R. A., Narpala, S., … Abdool Karim, S. (2023). Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial. BMJ Open, 13(8), e076843. https://doi.org/10.1136/bmjopen-2023-076843
Authors:
Sharana Mahomed
Nigel Garrett
Disebo Potloane
Izukanji T Sikazwe
Edmund Capparelli
Ishana Harkoo
Tanuja Narayansamy Gengiah
Nonhlanhla Yende Zuma
Farzana Osman
Leila Mansoor
Derseree Archary
Nqobile Myeni
Precious Radebe
Natasha Samsunder
Nicole Doria-Rose
Kevin Carlton
Lucio Gama
Richard A Koup
Sandeep Narpala
Leonid Serebryannyy
Penny Moore
Carolyn Williamson
Bruno Pozzetto
Catherine Hankins
Lynn Morris
Quarraisha Abdool Karim
Salim Abdool Karim
Affiliated Authors:
Quarraisha Abdool Karim
Salim Abdool Karim
Columbia Affiliation:
Subjects:
Acquired Immunodeficiency Syndrome (MeSH)
HIV Infections (MeSH)
Author Keywords:
epidemiology
hiv & aids
immunology
preventive medicine
public health
elink
Publication Type:
Article
Unique ID:
10.1136/bmjopen-2023-076843
PMID:
37640457
DOI:
10.1136/bmjopen-2023-076843
Journal:
BMJ Open
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: